72 Biggest Movers From Yesterday

Gainers

  • Protagonist Therapeutics, Inc. PTGX shares surged 72.9% to close at $8.11 on Wednesday. On Tuesday, Protagonist Therapeutics announced results from mid-stage study of PTG-300 in transfusion-dependent beta-thalassemia.
  • Ibio Inc IBIO shares jumped 51.1% to close at $0.2840 on continued momentum after the company joined the manufacturing USA's tissue Biofabrication initiative.
  • Kodiak Sciences Inc. KOD jumped 49.2% to close at $73.41. Kodiak Sciences priced 6 million share public offering of common stock at $46 per share.
  • Allakos Inc. ALLK gained 43.6% to close at $137.73 following reports stating the company is weighing a potential sale.
  • Relmada Therapeutics, Inc. RLMD rose 36.9% to close at $47.18. Relmada Therapeutics priced its common-stock offering of 3.33 million shares at $30 per share. The company expects to raise gross proceeds of $100 million from the offering, which is expected to close Dec. 6.
  • Anavex Life Sciences Corp. AVXL gained 28.4% to close at $3.03. Anavex Life Sciences will present ANAVEX 2-73 data at 12th Clinical Trials on Alzheimer's Disease 2019 Conference.
  • Applied Therapeutics, Inc. APLT shares climbed 21.7% to close at $24.00.
  • La Jolla Pharmaceutical Company LJPC gained 19.6% to close at $3.35.
  • Sequans Communications S.A. SQNS jumped 19% to close at $2.76.
  • Synthorx, Inc. THOR gained 18.7% to close at $21.45.
  • Galmed Pharmaceuticals Ltd. GLMD rose 17.9% to close at $6.72.
  • Pacific Drilling S.A. PACD climbed 16.9% to close at $3.05
  • Can-Fite BioPharma Ltd. CANF gained 16.7% to close at $4.40.
  • California Resources Corporation CRC rose 16.5% to close at $7.68.
  • DarioHealth Corp. DRIO rose 16.2% to close at $8.68.
  • Bio-Path Holdings, Inc. BPTH surged 15.6% to close at $8.25.
  • Vista Oil & Gas, S.A.B. de C.V. VIST shares rose 15.4% to close at $6.74.
  • Capstone Turbine Corporation CPST gained 15.3% to close at $3.8850.
  • Unique Fabricating, Inc. UFAB shares gained 14.8% to close at $4.57.
  • Mustang Bio, Inc. MBIO rose 14.8% to close at $3.88.
  • Lexicon Pharmaceuticals, Inc. LXRX gained 14.2% to close at $3.77 on continued momentum after the company announced it completed the initial stage for its Phase 2 clinical study of TELE-ABC.
  • Eloxx Pharmaceuticals, Inc. ELOX rose 13.3% to close at $5.47.
  • Rubius Therapeutics, Inc. RUBY gained 13.1% to close at $9.35.
  • Hudbay Minerals Inc. HBM rose 12.7% to close at $3.56.
  • Whiting Petroleum Corporation WLL climbed 12.5% to close at $5.05.
  • Cortexyme, Inc. CRTX climbed 12.5% to close at $31.87.
  • ImmunoGen, Inc. IMGN rose 12.4% to close at $4.00.
  • Hebron Technology Co., Ltd. HEBT jumped 12.1% to close at $6.28.
  • Centennial Resource Development, Inc. CDEV gained 11.8% to close at $3.36 following a larger-than-expected draw in US crude inventories as well as positive US-China trade reports and anticipation of further OPEC production cuts this year.
  • Jounce Therapeutics, Inc. JNCE surged 11.7% to close at $7.90.
  • IGM Biosciences, Inc. IGMS gained 11.6% to close at $22.21.
  • PG&E Corporation PCG gained 11.2% to close at $9.47. Strength may be due to macro optimism after Bloomberg reported that a US-China trade deal is getting closer.
  • BridgeBio Pharma, Inc. BBIO shares rose 11% to close at $33.92
  • Earthstone Energy, Inc. ESTE jumped 10.7% to close at $4.77.
  • Endologix, Inc. ELGX rose 10.7% to close at $2.5450.
  • Coda Octopus Group, Inc. CODA climbed 10.6% to close at $8.07.
  • Valaris plc VAL gained 10.5% to close at $4.43. Shares of oil companies are trading higher following a larger-than-expected draw in US crude inventories as well as positive US-China trade reports and anticipation of further OPEC production cuts this year.
  • Rapt Therapeutics Inc RAPT gained 10.3% to close at $27.53 after the company announced a collaboration with Hanmi Pharmaceutical to develop and commercialize FLX475 in Asia. Rapt is set to receive $10 million upfront and $108 million total milestones.
  • Endo International plc ENDP rose 10.3% to close at $5.51.
  • Transocean Ltd. RIG climbed 10.3% to close at $5.36 following a larger-than-expected draw in US crude inventories as well as positive US-China trade reports and anticipation of further OPEC production cuts this year.
  • Solaris Oilfield Infrastructure, Inc. SOI shares gained 10.1% to close at $11.57.
  • Express, Inc. EXPR jumped 10.1% to close at $3.91.
  • ESSA Pharma Inc. EPIX gained 10% to close at $5.60.
  • Front Yard Residential Corporation RESI shares surged 9.9% to close at $12.71 following Bloomberg article 'Amherst is in talks to buy Front Yard after activist pressure.'
  • Avita Medical Limited RCEL surged 9.2% to close at $8.56.
  • Tata Motors Limited ADR TTM shares rose 8.3% to close at $11.85 after the company reported strong US Land Rover sales and announced it will be raising passenger vehicle prices starting in 2020.
  • Universal Technical Institute, Inc. UTI shares rose 4.8% to close at $7.00. Argus Research upgraded Universal Technical from Sell to Hold.


Check out these big penny stock gainers and losers

Losers

  • Barnes & Noble Education, Inc. BNED shares tumbled 20.8% to close at $3.80 on Wednesday after the company reported downbeat Q2 results.
  • Revance Therapeutics, Inc. RVNC fell 17.6% to close at $16.61 after the company priced its 6.5 million share common stock offering at $17 per share.
  • Ardelyx, Inc. ARDX shares dipped 15.3% to close at $6.82. Shares surged Tuesday following results from the company's Phase 3 PHREEDOM trial in chronic kidney disease patients
  • China Rapid Finance Limited XRF shares dropped 15.1% to close at $1.91.
  • Kaleido BioSciences, Inc. KLDO fell 13% to close at $7.30.
  • Akers Biosciences, Inc. AKER dropped 11.4% to close at $5.50.
  • Acorda Therapeutics, Inc. ACOR dipped 11.2% to close at $1.83.
  • Bicycle Therapeutics plc BCYC fell 10.8% to close at $7.65.
  • Stage Stores, Inc. SSI dipped 10.3% to close at $4.89.
  • NuCana plc NCNA fell 9.5% to close at $6.73.
  • Kiniksa Pharmaceuticals, Ltd. KNSA shares declined 9.2% to close at $10.05.
  • OrganiGram Holdings Inc. OGI dipped 9.2% to close at $2.57 after the company announced at-the-market equity program.
  • IDEAYA Biosciences, Inc. IDYA fell 9% to close at $7.50.
  • Menlo Therapeutics Inc. MNLO dipped 8.7% to close at $3.98.
  • ViewRay, Inc. VRAY dropped 8.1% to close at $4.08 after the company priced its 41.55 million share common stock offering at $3.13 per share. B. Riley downgraded ViewRay from Buy to Neutral and lowered the price target from $9 to $5.
  • Instructure Inc INST tumbled 8% to close at $48.75 after the company agreed to be acquired by Thoma Bravo for $47.60 per share in cash.
  • Evolus, Inc. EOLS fell 7.8% to close at $12.70.
  • Oramed Pharmaceuticals Inc. ORMP fell 7.5% to close at $4.67 after dropping 11.71% on Tuesday.
  • Dynatrace, Inc. DT fell 7.4% to close at $25.01.
  • Myovant Sciences Ltd. MYOV declined 7% to close at $17.32.
  • Luckin Coffee Inc. LK dropped 6.6% to close at $29.84.
  • Zscaler Inc ZS shares fell 5.6% to close at $49.85 despite reporting a first quarter earnings beat. The company issued weak second quarter earnings guidance.
  • Immunomedics, Inc. IMMU fell 5.2% to close at $18.01 after the company announced a proposed offering of $250 million of common stock.
  • Workday, Inc. WDAY fell 4.7% to close at $165.39 after the company reported Q3 earnings and issued Q4 and FY20 guidance. The company said it does not expect its recent Scout RFP acquisition to have a notable impact on subscription revenue until 2022.
  • Cannae Holdings Inc CNNE shares fell 4% to close at $35.37. Cannae Holdings priced its upsized 6.5 million share public offering of common stock for gross proceeds of $214,500,000.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareIntegrated Telecommunication ServicesMovers From YesterdayTelecommunication ServicesTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!